Cemiplimab in AlloSCT/SOT Recipients With CSCC

Clinical trial NCT04339062 · COMPLETED

Trial details

NCT number: NCT04339062
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cutaneous Squamous Cell Carcinoma Advanced Cancer

Start date: 2020-11-03
Primary completion: 2023-06-12
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.